BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

Register
Register
Register

ProjectUpdated on 16 August 2026

AI-Enabled Quantitative MRI Platform for Early Disease Assessment

CEO at CAPRiser Group

Canada

About

A Hong Kong-developed medical-imaging venture is commercializing a patented, software-based enhancement for existing MRI systems. The technology enables faster, non-invasive quantitative assessment of tissue changes associated with chronic diseases, initially focusing on liver fibrosis, with potential applications in neurological and musculoskeletal conditions.

The project has completed technical validation and is progressing through clinical and commercial development. It is seeking strategic investors, medical-imaging partners, healthcare operators and international commercialization partners to support clinical validation, regulatory development and global market expansion. Further information will be provided to qualified parties under appropriate confidentiality arrangements.

Project Location

  • China (Hong Kong)

Project Format

  • Private Project

Go Global Project

  • No

ESG (Environmental, Social, and Governance)

  • No

Project Stage

  • Investment / Financing Discussion

Main Project Sector

  • Technology

Total Project Value

  • 7,500,001 to 10,000,000 USD

Investment Capital Required

  • 1,000,001 to 2,500,000 USD

Interested Format of Cooperation

  • Convertible Loan
  • Direct Equity Investment
  • Open for Negotiation

Preferred Financing Model

  • Equity

Type(s) of Last Financing Round of the project (if Applicable)

  • Equity (private)

Main Service(s) Required

  • Financial Services

Organisation

Similar opportunities